SU628930A1 - Device for introducing medicinal powders - Google Patents

Device for introducing medicinal powders

Info

Publication number
SU628930A1
SU628930A1 SU742097190A SU2097190A SU628930A1 SU 628930 A1 SU628930 A1 SU 628930A1 SU 742097190 A SU742097190 A SU 742097190A SU 2097190 A SU2097190 A SU 2097190A SU 628930 A1 SU628930 A1 SU 628930A1
Authority
SU
USSR - Soviet Union
Prior art keywords
medicinal powders
introducing medicinal
introducing
powders
cavity
Prior art date
Application number
SU742097190A
Other languages
Russian (ru)
Inventor
Иван Михайлович Бондарев
Original Assignee
Московский научно-исследовательский институт туберкулеза
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Московский научно-исследовательский институт туберкулеза filed Critical Московский научно-исследовательский институт туберкулеза
Priority to SU742097190A priority Critical patent/SU628930A1/en
Application granted granted Critical
Publication of SU628930A1 publication Critical patent/SU628930A1/en

Links

Description

При практическом использовании устройства уровень порошка а емкости  е превышает половины длины цек;гральной трубки. .Подсоединение емкости с лекарственным препаратом к игле производ т при сжатой груше , что обеспечивает в первой фазе работы засасывание воздуха нз каверны в емкость дл  лекарственного пред рата, а при второй фазе (сжатии) порошок, увлекаемый тем же объемом eosjGiyxa, выталкиваетс  в каверну .In practical use of the device, the level of powder and capacity e exceeds half the length of the grinding tube. .Connecting the drug container to the needle is performed with a compressed pear, which ensures that in the first phase of the operation air is drawn from the cavity into the container for the medicinal product, and during the second phase (compression) the powder carried along by the same volume of eosjGiyxa is pushed into the cavity.

Описанное устройство обеспечивает введ ние лекарственного препарата в  атологнческую полость с использованием мнниMaJibHoro объема воздуха дл  устранени  перераст женн  стенок полости.The described device provides for the introduction of a medicament into the atrial cavity using a plurality of air volume to eliminate the overgrowth of the cavity walls.

Claims (2)

1.Авторское свидетельство СССР № 171094, кл. А 61 М 13/00, 1964.1. USSR author's certificate number 171094, cl. A 61 M 13/00, 1964. 2.Патент Франции № 2004243, кл. В 05 В И/00, 1969.2. The patent of France No. 2004243, cl. B 05 W I / 00, 1969.
SU742097190A 1974-11-26 1974-11-26 Device for introducing medicinal powders SU628930A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU742097190A SU628930A1 (en) 1974-11-26 1974-11-26 Device for introducing medicinal powders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU742097190A SU628930A1 (en) 1974-11-26 1974-11-26 Device for introducing medicinal powders

Publications (1)

Publication Number Publication Date
SU628930A1 true SU628930A1 (en) 1978-10-25

Family

ID=20607598

Family Applications (1)

Application Number Title Priority Date Filing Date
SU742097190A SU628930A1 (en) 1974-11-26 1974-11-26 Device for introducing medicinal powders

Country Status (1)

Country Link
SU (1) SU628930A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5740794A (en) * 1994-09-21 1998-04-21 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US6089228A (en) * 1994-09-21 2000-07-18 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US6679256B2 (en) 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
WO2006088894A2 (en) 2005-02-15 2006-08-24 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
EP2263652A1 (en) 1998-11-12 2010-12-22 Elan Pharma International Limited Aerosols comprising nanoparticle drugs
US8161969B2 (en) 1998-06-04 2012-04-24 Novartis Ag Dry powder dispersing apparatus and methods for their use
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
US8357696B2 (en) 2005-05-18 2013-01-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en) 2005-05-18 2013-05-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9700529B2 (en) 2002-05-03 2017-07-11 Nektar Therapeutics Particulate materials
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6681767B1 (en) 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US6089228A (en) * 1994-09-21 2000-07-18 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5740794A (en) * 1994-09-21 1998-04-21 Inhale Therapeutic Systems Apparatus and methods for dispersing dry powder medicaments
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US5993783A (en) * 1995-04-14 1999-11-30 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder α1-antitrypsin
US8161969B2 (en) 1998-06-04 2012-04-24 Novartis Ag Dry powder dispersing apparatus and methods for their use
EP2263652A1 (en) 1998-11-12 2010-12-22 Elan Pharma International Limited Aerosols comprising nanoparticle drugs
US6679256B2 (en) 1999-12-17 2004-01-20 Nektar Therapeutics Systems and methods for extracting powders from receptacles
US10188614B2 (en) 2002-05-03 2019-01-29 Nektar Therapeutics Particulate materials
US10945972B2 (en) 2002-05-03 2021-03-16 Nektar Therapeutics Particulate materials
US9700529B2 (en) 2002-05-03 2017-07-11 Nektar Therapeutics Particulate materials
EP2353590A1 (en) 2005-02-15 2011-08-10 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
WO2006088894A2 (en) 2005-02-15 2006-08-24 Elan Pharma International Limited Aerosol and injectable formulations of nanoparticulate benzodiazepine
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272A2 (en) 2005-05-18 2013-05-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US10987357B2 (en) 2005-05-18 2021-04-27 Horizon Orphan, LLC Aerosolized fluoroquinolones and uses thereof
US8357696B2 (en) 2005-05-18 2013-01-22 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524734B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US10149854B2 (en) 2008-10-07 2018-12-11 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9717738B2 (en) 2008-10-07 2017-08-01 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US9326936B2 (en) 2008-10-07 2016-05-03 Raptor Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
US10722519B2 (en) 2008-10-07 2020-07-28 Horizon Orphan Llc Aerosol fluoroquinolone formulations for improved pharmacokinetics
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
US11020481B2 (en) 2008-10-07 2021-06-01 Horizon Orphan Llc Topical use of levofloxacin for reducing lung inflammation
US9700564B2 (en) 2009-09-04 2017-07-11 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10231975B2 (en) 2009-09-04 2019-03-19 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
US10792289B2 (en) 2009-09-04 2020-10-06 Horizon Orphan Llc Use of aerosolized levofloxacin for treating cystic fibrosis
WO2012106382A1 (en) 2011-01-31 2012-08-09 Genoa Pharmaceuticals, Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
EP4059499A1 (en) 2011-01-31 2022-09-21 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof

Similar Documents

Publication Publication Date Title
SU628930A1 (en) Device for introducing medicinal powders
BE860727A (en) NEW TRANS-N- (2-AMINOCYCLOALIPHATIC) BENZAMIDES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR2353290A1 (en) NEW PROSTAGLANDIN ANALOGUES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
BE827127A (en) NEW DERIVATIVES OF OXY-16 PROSTANOIC ACID, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC USE
IE45048L (en) Syringe.
GB1335797A (en) Multiple dosage inoculator
FR2273522A2 (en) NEW ALCANOLAMINE DERIVATIVE, ITS PREPARATION PROCESS AND MEDICINAL PRODUCT CONTAINING IT
BE827777A (en) NEW CARBOXYLIC ACID AMIDS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR2274294A1 (en) NEW CARBOXYLIC ACID AMIDS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
ZA752067B (en) Process for preparing a pharmaceutical preparation containing zinc-zn suitable for medical use
BE829052A (en) NEW SUBSTITUTES PHENYLGUANIDINES, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR2276048A1 (en) NEW CYCLOHEXANOL ESTERS, THEIR SALTS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM
BE848310A (en) DI ACIDS (2 PHENOXY-CARBOXYL ALKANES), THEIR PREPARATION PROCESS AND THEIR USE AS MEDICINAL PRODUCTS
BE794414A (en) NEW AMINO-ALCOHOLS, THEIR PREPARATION AND THEIR APPLICATION AS A MEDICINAL PRODUCT
Merson Numerical integration of the differential equations of celestial mechanics
BE786713A (en) NEW AMINO-ALCOHOLS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2346005A1 (en) NEW LACTONS OF FREE ACIDS OF THE PROSTAGLANDIN TYPE, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
BE831421A (en) NEW SUBSTITUTED PHENYLISOTHIOUREES, THEIR PROCESS OF PREPARATION AND THE MEDICINAL PRODUCT CONTAINING THEM
BE861697A (en) NEW POLYCYCLIC ANTIBIOTICS, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
IT1085297B (en) PYRAZOL-PYRIMIDINYL (TION) (TIOL) -PHOSPHORIC (PHOSPHONIC) ESTERS, PROCEDURE FOR THEIR PREPARATION AND USE WITH INSECTICIDES AND ACARICIDES
NL7507422A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH BLOOD PRESSURE-LOWERING ACTION, SUCH MEDICINAL PRODUCT AND A PROCESS FOR PREPARING THE ACTIVE COMPOUNDS.
CA1029305A (en) Infusion solution for the treatment of tachycardiac disturbances of heart rhythm and use thereof
ES436179A1 (en) Physiological substances for intensifying the pharmacological effect of drugs
FR2291758A1 (en) NEW BENZODIAZEPINES, THEIR PREPARATION AND THE MEDICINAL PRODUCT CONTAINING THEM
JPS5356317A (en) Preparation of capsulated drug, and capsules and trays preparig the same